Continuing controversy in the management of concomitant coronary and carotid disease: an overview
- PMID: 10854680
- DOI: 10.1016/s0167-5273(00)00251-5
Continuing controversy in the management of concomitant coronary and carotid disease: an overview
Abstract
Objectives: To perform an analytical overview of the risk factors, pathogenesis of stroke and the strategies for the management of concomitant coronary artery disease and carotid artery stenosis (CAS). Four strategies were analysed; CABG in the presence of CAS, combined (CE+CABG), reverse (CABG+CE<3 months) and prior staged (CE+CABG<3 months).
Methods: A literature search formed the basis of a reference database. Outcome was assessed by the 30-day permanent stroke and mortality rate for the different approaches. Accrued rates of permanent stroke and mortality rate were expressed in terms of mean stroke and mortality rate (MSR, MMR). Data was analysed comparatively and expressed in terms of P value, odds ratio and confidence limits.
Results: 33 different risk factors for stroke at CABG were identified. Significant factors included: ascending aortic atheroma, emergency procedures, impaired left ventricular function, cardioplegia and peripheral vascular disease. Risk of stroke at CABG increased with higher grade CAS (50 vs. 80%, P=0.009). Pathogenesis of stroke at CABG is multifactorial; the role of flow limiting CAS is controversial and other mechanisms are implicated. Analysis of the four strategies revealed that in the Prior Stage (n=573) the MSR was 1.5% and MMR 5.9%, in the Unprotected CABG+CAS series the MSR was 3.8% (n=840) and MMR (n=596) 4.4%, in the Reverse stage series (n=83) the MSR was 2.4%, and MMR 4.8%. For Combined procedures (n=3,295) the MSR was 3.9% and MMR 4.5%. Comparative analysis indicated a significant reduction in stroke for Prior vs. Combined (1.5 vs. 3.9%, P=0.007, odds 0.39, CI 0.2-0.77) with a higher mortality (5.9 vs. 4.5%, P=0.1, odds 1.41, Cl 0.96-2.06, NS). The stroke rate in the Prior stage also remained significantly lower compared to the Unprotected CABG group both mixed (P=0.015) and asymptomatic CAS (P=0.047). When total risks (MSR+MMR), were analysed, similar results were found between the groups; Prior 7.4%, Reverse stage 7.2%, Combined 8.4%, Unprotected CABG+ >50% CAS 11.5%.
Conclusions: Stroke at CABG is due to multiple risk factors, one of which is high-grade carotid stenosis. Pathophysiology of stroke, although multifactorial, supports embolism rather than flow limitation as the primary mechanism. Lack of randomised trials has made it impossible to draw firm conclusions regarding the best management strategy. There was no significant difference in the overall stroke and mortality risk between the various strategies, however, subgroup analysis suggests that, when carefully selected, patients do better by staging the operations. In our opinion patients without severe cardiac disease should be considered for Prior staging and the rest for Combined procedure. The role of reverse staging needs further evaluation.
Similar articles
-
Comparison of Trends and In-Hospital Outcomes of Concurrent Carotid Artery Revascularization and Coronary Artery Bypass Graft Surgery: The United States Experience 2004 to 2012.JACC Cardiovasc Interv. 2017 Feb 13;10(3):286-298. doi: 10.1016/j.jcin.2016.11.032. JACC Cardiovasc Interv. 2017. PMID: 28183469
-
Trends and outcomes of concurrent carotid revascularization and coronary bypass.J Vasc Surg. 2008 Aug;48(2):355-360; discussion 360-1. doi: 10.1016/j.jvs.2008.03.031. Epub 2008 Jun 24. J Vasc Surg. 2008. PMID: 18572353
-
Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting.J Vasc Surg. 2011 Oct;54(4):993-9; discussion 998-9. doi: 10.1016/j.jvs.2011.03.284. Epub 2011 Jun 23. J Vasc Surg. 2011. PMID: 21703806 Clinical Trial.
-
Management strategy for simultaneous carotid endarterectomy and coronary revascularization.Ann Thorac Surg. 1997 Oct;64(4):1013-8. doi: 10.1016/s0003-4975(97)00795-9. Ann Thorac Surg. 1997. PMID: 9354519 Review.
-
Synchronous versus staged carotid artery stenting and coronary artery bypass graft for patients with concomitant severe coronary and carotid artery stenosis: A systematic review and meta-analysis.Vascular. 2020 Dec;28(6):808-815. doi: 10.1177/1708538120929506. Epub 2020 Jun 3. Vascular. 2020. PMID: 32493182
Cited by
-
Carotid artery stenting prior to coronary artery bypass grafting in patients with carotid stenosis: Clinical outcomes.Interv Neuroradiol. 2023 Feb;29(1):30-36. doi: 10.1177/15910199221067665. Epub 2022 Mar 24. Interv Neuroradiol. 2023. PMID: 35331026 Free PMC article.
-
[Carotid stenosis concomitant to coronary artery disease].Chirurg. 2004 Jul;75(7):667-71. doi: 10.1007/s00104-004-0903-z. Chirurg. 2004. PMID: 15221090 German.
-
The preoperative neurological evaluation.Neurohospitalist. 2013 Oct;3(4):209-20. doi: 10.1177/1941874413476042. Neurohospitalist. 2013. PMID: 24198903 Free PMC article. Review.
-
Management of asymptomatic carotid stenosis in patients undergoing general and vascular surgical procedures.J Neurol Neurosurg Psychiatry. 2005 Oct;76(10):1332-6. doi: 10.1136/jnnp.2005.066936. J Neurol Neurosurg Psychiatry. 2005. PMID: 16170071 Free PMC article.
-
Endovascular carotid stenting in patients scheduled for cardiac surgery: if yes, which first?AJNR Am J Neuroradiol. 2006 Jan;27(1):11; author reply 11-2. AJNR Am J Neuroradiol. 2006. PMID: 16418348 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous